Abnormal glomerular response to atrial natriuretic peptide in rats with aortocaval fistulas

Journal of the American Society of Nephrology

Volumn 7, Issue 7, 1996, Pages 1038-1044

  Norling, Laura L ^a   Thornhill, Barbara A ^b   Chevalier, Robert L ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

cGMP; Heart failure; Phosphodiesterase; Sodium retention

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; PHOSPHODIESTERASE; PROBENECID; SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLOMERULUS; HEART FAILURE; HEART OUTPUT; HEMODYNAMIC MONITORING; HYDROLYSIS; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM RETENTION; VASCULAR RESISTANCE;

EID: 0030372740     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Koepke JP, DiBona GF: Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders. Am J Physiol 1987;252:F865-F871.
2. Perrella MA, Margulies KB, Burnett JC Jr: Pathophysiology of congestive heart failure: Role of atrial natriuretic factor and therapeutic implications. Can J Physiol Pharmacol 1991;69:1576-1581.
3. Francis GS: Neurohumoral mechanisms involved in confestive heart failure. Am J Cardiol 1985;55:15A-21A.
4. Schunkert H, Tang S-S, Litwin SE, et al.: Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res 1993;27: 731-735.
5. Villarreal D, Freeman RH, Davis JO, Verburg KM, Van RC: Atrial natriuretic factor secretion in dogs with experimental high-output heart failure. Am J Physiol 1987; 252:H692-H696.
6. Winaver J, Hoffman A, Burnett JC Jr, Haramati A: Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol 1988;254:R776-R784.
7. Garcia R, Lachance D, Thibault G: Atrial natriuretic factor release and natriuresis in rats with high-output heart failure. Am J Physiol 1990;259:H1374-H1379.
8. Abassi Z, Burnett JC Jr, Grushka E, Hoffman A, Hamarati A, Winaver J: Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure. Am J Physiol 1991;261:R858-R864.
9. Hoffman A, Burnett JC Jr, Haramati A, Winaver J: Effects of atrial natriuretic factor in rats with experimental high-output heart failure. Kidney Int 1988;33:656-661.
10. Isnard R, Carayon A, Eurin J, et al.: Glomerular atrial natriuretic factor receptors in experimental congestive heart failure. Am J Physiol 1993;265:H923-H928.
11. Chevalier RL, Gomez RA, Carey RM, Peach MJ, Linden JM: Renal effects of atrial natriuretic peptide infusion in young and adult rats. Pediatr Res 1988;24:333-337.
12. Norling LL, Vaughan CA, Chevalier RL: Maturation of cGMP response to ANP by isolated glomeruli. Am J Physiol 1992;262:F138-F143.
13. Huang C-L, Ives HE, Cogan MG: In vivo evidence that cGMP is the second messenger for atrial natriuretic factor. Proc Natl Acad Sci USA 1986;83:8015-8018.
14. Garcia R, Diebold S: Simple, rapid and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 1990;24:430-432.
15. Chevalier RL, Thornhill BA, Gomez RA: EDRF modulates renal hemodynamics during unilateral ureteral obstruction in the rat. Kidney Int 1992;42:400-406.
16. Norling LL, von Geldern T, Chevalier RL: Maturation of A71915-dependent inhibition of atrial natriuretic peptide-stimulated cyclic GMP production in isolated rat glomeruli. Biol Neonate 1994;66:294-301.
17. Kincaid RL, Manganiello VC: Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates. Methods Enzymol 1988;159:457-470.
18. Margulies KB, Heublein DM, Perrella MA, Burnette JC Jr: ANF-mediated renal cGMP generation in congestive heart failure. Am J Physiol 1991;260:F562-F568.
19. Michel J-B, Mercadier J-J, Galen F-X, et al.: Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats. Cardiovasc Res 1990;24:946-952.
20. Moe GW, Canepa-Anson R, Armstrong PW: Atrial natriuretic factor: Pharmacokinetics and cyclic cGMP response in relation to biologic effects in severe heart failure. J Cardiovasc Pharmacol 1992;19:691-700.
21. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamoaka O, Kinoshita M: Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 1993;87:70-75.
22. Garcia R, Bonhomme M-C, Schiffrin EL: Divergent regulation of atrial natriuretic factor receptors in high-output heart failure. Am J Physiol 1992;263:H1790-H1797.
23. Chinkers M, Garbers DL, Chang M-S, et al.: A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (Lond) 1989;338:78-83.
24. Ballerman BJ, Hoover RL, Karnovsky MJ, Brenner BM: Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. J Clin Invest 1985;76:2049-2056.
25. Hamet P, Pang SC, Tremblay J: Atrial natriuretic factor-induced egression of cyclic guanosine 3′-5′ monophosphate in cultured vascular smooth muscle cells and endothelial cells. J Biol Chem 1989;264:12364-12369.
26. Light DB, Corbin JD, Stanton BA: Dual ion channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase. Nature (Lond) 1990;344:336-339.
27. Neant F, Bailly C: Luminal and intracellular cGMP inhibit the mTAL reabsorptive capacity through different pathways. Kidney Int 1993;44:741-746.
28. Chevalier RL, Fang GD, Garmey M: Extracellular cyclic GMP inhibits transepithelial sodium transport in LL-CPK1 renal tubular cells. Am J Physiol 1996: 270:F283-F288.
29. Valentin JP, Qiu C, Muldowney WP, Ying W-Z, Gardner DG, Humphreys MH: Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 1992;90:1302-1312.
30. Lee RW, Raya TE, Michael U, Foster S, Meeks T, Goldman S: Captopril and ANP changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure. J Pharmacol Exp Ther 1992;260:349-354.
31. Perrella MA, Aarhus LL, Heublein DM, Lewicki JA, Burnett JC Jr: Biologic role of atrial natriuretic factor clearance receptor in congestive heart failure. Am J Physiol 1993;265:H401-H408.
32. Perrella MA, Margulies KB, Wei C-M, Aarhus LL, Heublein DM, Burnett JC Jr: Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs. J Clin Invest 1991;87:1649-1655.
33. Yechieli H, Kahana L, Haramati A, Hoffman A, Winaver J: Regulation of renal glomerular and papillary ANP receptors in rats with experimental heart failure. Am J Physiol 1993;265:F119-F125.
34. Dibona GF, Herman PJ, Sawin LI: Neuronal control of renal function in edema forming states. Am J Physiol 1988;254:R1017-R1024.
35. Qing G, Garcia RC: Chronic captopril and losartan (DuP 753) administration in rats with high-output heart failure. Am J Physiol 1992;263:H833-H840.
36. Haneda M, Kikkawa R, Maeda S, et al.: Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int 1991;40:188-194.
37. Bethke T, Klimkiewicz A, Kohl C, et al.: Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts. J Cardiovasc Pharmacol 1991;18:386-397.